Earum Pharmaceuticals Ltd

Earum Pharmaceuticals Ltd (542724)


Key Stats

Day's Price Range
52-Week Price Range
1 Month Return9.16 %
3 Month Return-32.52 %
1 Year Return-89.04 %

Company Financials

  • Annual
Value in ₹ crore

Peer Comparsion

Rank 299
Rank 303
Rank 326
Dividend Yield
Rank 177
Rank 178
Price To Book Ratio
Rank 262
Debt To Asset
Rank 316

Company Information

Earum Pharmaceuticals Limited was originally incorporated as a private limited company with the name Earum Pharmaceuticals Private Limited onJuly 26 2012. Further pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10 2019 the company was converted into a Public Limited Company and consequently the name of the Company was changed from Earum Pharmaceuticals Private Limited to Earum Pharmaceuticals Limited on January 23 2019.Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel were the initial subscribers to Memorandum of Association of the Company.The Company is engaged in the pharmaceutical business involving marketing trading and distribution of wide range of pharmaceutical formulation products such as antibiotic drugs antimalarial drugs antiallergic anti cold drugs analgesic/ antipyretic anti inflammatory drugs dermatology products cerebral activator drugs neurological drugs gastro intestinal drugs steroids gynecology drugs calcium multivitamins antioxidants and injections. At present the company offers around 125 pharmaceutical formulation products of which around 24 products are marketed under its own brand name the manufacturing of which is outsourced by the company to third parties. Apart from pharmaceutical formulation products the company also deals in trading of active pharmaceutical ingredients APIs such as Levofloxacin Hemihdrate IP Albendazol IP Amoxicillin Trihydrate IP etc.
OrganisationEarum Pharmaceuticals Ltd